There is a growing body of research indicating that patients with RA can be categorized into two main groups depending on their ACPA status: ACPA-positive RA (also known as ACPA+ RA) and ACPA-negative RA (also known as ACPA− RA). The gene discussed is PRTN3; the disease is rheumatoid arthritis.